English | Español

Regulatory
+ Regulatory
Patient Daily | Apr 27, 2023

Digital therapeutics: at an inflection point
+ Community
Patient Daily | Apr 27, 2023

Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
+ Technology/Innovation
Patient Daily | Apr 27, 2023

Clinical ink Announces New Continuous Glucose Monitoring Solution
+ Regulatory
Patient Daily | Apr 27, 2023

Augmedix Secures Strategic Financing from HCA Healthcare and Redmile Group
+ Community
Patient Daily | Apr 27, 2023

Augmedix Announces Partnership with HCA Healthcare to Accelerate the Development of AI-enabled Ambient Documentation
+ Community
Patient Daily | Apr 27, 2023

Bristol Myers Squibb Strengthens Cell Therapy Capabilities by Adding New U.S. Manufacturing Facility for Viral Vector Production
+ Technology/Innovation
Patient Daily Report | Apr 27, 2023

Study suggests eating peanuts may benefit heart health in young, healthy individuals: 'Peanuts can play an important role in promoting heart health'
+ Technology/Innovation
Patient Daily | Apr 26, 2023

Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation